Literature DB >> 33791475

The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis.

Kristina A Westcott1, Frances Wilkins1, Amelia Chancellor1, Alan Anderson1, Simon Doe1, Carlos Echevarria1, Stephen J Bourke1.   

Abstract

People with cystic fibrosis (CF) were advised to undertake 'shielding' at home during the COVID-19 pandemic to reduce their risk of infection. We studied the impact shielding had on their wellbeing, mental health (GAD-7 and PHQ-9 scores) and adherence to treatment. 63 (46%) of 137 people surveyed responded (19 anonymously; 44 gave their identity). Most (94%) adhered to shielding advice 'all the time/often' but many (76%) found this difficult with disruption of their routines, relationships and exercise habits. Treatment adherence rates were high and continued during COVID-19. Depression scores were low and remained stable. Clinically significant anxiety rates rose from 27% pre-COVID-19 to 54% during COVID-19 and seven patients requested a psychology consultation from this study. There is a need to monitor the wellbeing of people with CF during the ongoing COVID-19 pandemic. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  COVID-19 shielding; adherence; anxiety; cystic fibrosis; depression

Year:  2021        PMID： 33791475      PMCID： PMC8004337          DOI： 10.7861/fhj.2020-0205

Source DB:  PubMed          Journal:  Future Healthc J        ISSN： 2514-6645


  11 in total

1.  An Australian study of adolescents with cystic fibrosis: perceived supportive and nonsupportive behaviors from families and friends and psychological adjustment.

Authors:  B W Graetz; R H Shute; M G Sawyer
Journal:  J Adolesc Health       Date:  2000-01       Impact factor: 5.012

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Current characteristics, challenges and coping strategies of young people with cystic fibrosis as they transition to adulthood.

Authors:  Kristina Askew; Jade Bamford; Nicholas Hudson; Juliana Moratelli; Rachel Miller; Alan Anderson; Simon Doe; Stephen J Bourke
Journal:  Clin Med (Lond)       Date:  2017-04       Impact factor: 2.659

4.  Ways of coping with cystic fibrosis: implications for treatment adherence.

Authors:  J Abbott; M Dodd; L Gee; K Webb
Journal:  Disabil Rehabil       Date:  2001-05-20       Impact factor: 3.033

5.  Hoping to live a "normal" life whilst living with unpredictable health and fear of death: impact of cystic fibrosis on young adults.

Authors:  Lorraine Higham; Shenaz Ahmed; Mushtaq Ahmed
Journal:  J Genet Couns       Date:  2012-12-14       Impact factor: 2.537

Review 6.  Cochrane corner: psychological interventions for individuals with cystic fibrosis and their families.

Authors:  Lutz Goldbeck; Astrid Fidika; Marion Herle; Alexandra L Quittner
Journal:  Thorax       Date:  2015-06-19       Impact factor: 9.139

7.  Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries.

Authors:  Alexandra L Quittner; Lutz Goldbeck; Janice Abbott; Alistair Duff; Patrick Lambrecht; Amparo Solé; Marijke M Tibosch; Agneta Bergsten Brucefors; Hasan Yüksel; Paola Catastini; Laura Blackwell; Dave Barker
Journal:  Thorax       Date:  2014-09-21       Impact factor: 9.139

8.  Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs.

Authors:  Romola S Bucks; Katharine Hawkins; T C Skinner; Sandra Horn; Paul Seddon; Rob Horne
Journal:  J Pediatr Psychol       Date:  2009-02-05

9.  Impact of COVID-19 on people with cystic fibrosis.

Authors:  Carla Colombo; Pierre-Régis Burgel; Silvia Gartner; Silke van Koningsbruggen-Rietschel; Lutz Naehrlich; Isabelle Sermet-Gaudelus; Kevin W Southern
Journal:  Lancet Respir Med       Date:  2020-04-15       Impact factor: 30.700

10.  A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.

Authors:  Rebecca Cosgriff; Susannah Ahern; Scott C Bell; Keith Brownlee; Pierre-Régis Burgel; Cass Byrnes; Harriet Corvol; Stephanie Y Cheng; Alexander Elbert; Albert Faro; Christopher H Goss; Vincent Gulmans; Bruce C Marshall; Edward McKone; Peter G Middleton; Rasa Ruseckaite; Anne L Stephenson; Siobhán B Carr
Journal:  J Cyst Fibros       Date:  2020-04-25       Impact factor: 5.482
View more
  4 in total

1.  Health-related quality of life, uncertainty and coping strategies in solid organ transplant recipients during shielding for the COVID-19 pandemic.

Authors:  Siobhan C McKay; Hanns Lembach; Angus Hann; Kelvin Okoth; Joy Anderton; Krishnarajah Nirantharakumar; Laura Magill; Barbara Torlinska; Matthew Armstrong; Jorge Mascaro; Nicholas Inston; Thomas Pinkney; Aaron Ranasinghe; Richard Borrows; James Ferguson; John Isaac; Melanie Calvert; M Thamara P R Perera; Hermien Hartog
Journal:  Transpl Int       Date:  2021-09-16       Impact factor: 3.842

Review 2.  Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.

Authors:  Eusebi Chiner-Vives; Rosa Cordovilla-Pérez; David de la Rosa-Carrillo; Marta García-Clemente; José Luis Izquierdo-Alonso; Remedios Otero-Candelera; Luis Pérez-de Llano; Jacobo Sellares-Torres; José Ignacio de Granda-Orive
Journal:  Arch Bronconeumol       Date:  2022-04-15       Impact factor: 6.333

3.  Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis.

Authors:  Beth A Smith; Anna M Georgiopoulos; Amy Mueller; Janice Abbott; Paula Lomas; Enid Aliaj; Alexandra L Quittner
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

4.  Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study.

Authors:  Patrik Bachtiger; Alexander Adamson; William A Maclean; Mihir A Kelshiker; Jennifer K Quint; Nicholas S Peters
Journal:  JMIR Public Health Surveill       Date:  2021-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.